Username:   Password:

Company Interview Excerpt
A.MALACHI MIXON III - INVACARE CORPORATION (IVC)
Full article published: 7/24/2006    


For Subscribers

Get this article online now!

Order just this article

TWST: Please introduce us to Invacare.
Mr. Mixon: Invacare Corporation is the world's largest manufacturer and distributor of medical products used in the home. We began as a small LBO 27 years ago when sales were then $19 million. Today we are a $1.5 billion NYSE corporation, manufacturing around the globe and marketing to approximately 80 countries.

TWST: Give us some idea of what the marketplace looks like, what the dynamics are. Who are your clients, your competitors?
Mr. Mixon: We define our worldwide home medical equipment marketplace as approximately $6 billion. We add to that a $2 billion disposables market in the US. Normally, our market has an internal growth rate of 3% to 5%; however, in the last two to three years, the United States government (Medicare) has enacted a number of changes in reimbursement that have caused the market to temporarily stagnate, and decline in some sectors. Contrary to almost all published data about the cost- effectiveness of home care versus institutionalized care, our current government's attitude has been to cut reimbursement in home medical care. This compromises the quality of life for our seniors and ultimately will contribute to longer institutional stays and more frequent readmissions. I guess these cuts are partially to pay for the new prescription drug plan, the war in Iraq, Katrina and other areas creating the US deficit. It certainly has been a challenge for our industry. But overall, people are aging around the world, and nothing is more important to them than their health care. They prefer to remain out of institutions to the extent they can, and Invacare is currently in the middle of that trend. The company has certainly enjoyed considerable growth over the 27 years that I have led it.

Tickers included in this excerpt: IVC


For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.

 

TWST Newsletter

Fill out your e-mail address
to receive our newsletter!

Why TWST?

Investors:
Thousands of easy-to-read verbatim CEO interviews
Must-have backgrounder before meeting management
Analyst interviews complement published research
Roundtables offer multi-broker perspective
Unique tool for investment clubs
Professional money managers discuss strategy and holdings.

Business Researchers:
Company research from C-level perspective
Strategic planning and partnership information
Wall Street view of Companies and Sectors
Research for potential Client needs
Market intelligence

click for more info